<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04757012</url>
  </required_header>
  <id_info>
    <org_study_id>En cours</org_study_id>
    <secondary_id>2020-A01369-30</secondary_id>
    <nct_id>NCT04757012</nct_id>
  </id_info>
  <brief_title>Efficacy Study of a Device Allowing Broadcasting Maternal Voice and Heartbeat in Preterm Newborn (CALIPREM)</brief_title>
  <acronym>CALIPREM</acronym>
  <official_title>Pilot Study to Evaluate the Benefits of Preterm Newborn Exposition to a Maternal Voice and Heardbeat Recording During Hospital Stay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the benefits of an exposition to a maternal voice&#xD;
      and heartbeat recording during hospital stay for preterm newborns. For that, we use of a&#xD;
      specific neonatal device &quot;Calinange&quot; able to record maternal voice and heartbeats and to&#xD;
      restore it with a sound level control. We hypothesize an improvement of the well being of the&#xD;
      newborn under Calinange exposition.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Immediately after birth, preterm newborns are immersed in a hostile environment of intensive&#xD;
      care unit with light, sound and painful stimulations. Previously, exposure to maternal voice&#xD;
      has demonstrated improvement on infants' statements: reduction of bradycardia, desaturation&#xD;
      events, improvement of tolerance feeding and sleep. Unfortunatly in most of the N ICU in&#xD;
      France, the mothers' presence attendance time is reduced because of the absence of&#xD;
      accommodation structure. The use of a specific neonatal device able to daily record maternal&#xD;
      voice and hearbeats and to restore it when mother is gone could improve the environment and&#xD;
      promote the well-being of the newborn.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate variability / NIPE Index</measure>
    <time_frame>Change of the NIPE index before and after intervention. Each baby is his own control. Nipe index is recorded 10 minutes before and 10 minutes after the intervention (Calinange (day 2/4/6) or nothing (day 1/3/5))</time_frame>
    <description>Recorded heart rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of desaturation events</measure>
    <time_frame>Change of the NIPE index before and after intervention. Each baby is his own control. Nipe index is recorded 10 minutes before and 10 minutes after the intervention (Calinange (day 2/4/6) or nothing (day 1/3/5))</time_frame>
    <description>Change in desaturation events before and after intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of apnoeic events</measure>
    <time_frame>Change of the NIPE index before and after intervention. Each baby is his own control. Nipe index is recorded 10 minutes before and 10 minutes after the intervention (Calinange (day 2/4/6) or nothing (day 1/3/5))</time_frame>
    <description>Change in apneic events before and after intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of bradycardia events</measure>
    <time_frame>Change of the NIPE index before and after intervention. Each baby is his own control. Nipe index is recorded 10 minutes before and 10 minutes after the intervention (Calinange (day 2/4/6) or nothing (day 1/3/5))</time_frame>
    <description>Change in bradycardia events before and after intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the benefits for the nurses</measure>
    <time_frame>To be completed after each use of calinange ether on day 2, 4 and 6</time_frame>
    <description>Evaluation questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the benefits for the mother</measure>
    <time_frame>At day 7, after the end of intervention</time_frame>
    <description>Satisfaction questionnaire</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Preterm Newborn</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>calinange</intervention_name>
    <description>calinange</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hospitalised premature newborn in Port-Royal NICU&#xD;
&#xD;
          -  age between 3 and 6 daysof life&#xD;
&#xD;
          -  gestational age between 27+0 and 31+6 weeks&#xD;
&#xD;
          -  hospitalisation in one bed room&#xD;
&#xD;
          -  parental consents&#xD;
&#xD;
          -  beneficiaries social security scheme&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  occurrence of one or more non-inclusion criteria&#xD;
&#xD;
          -  Non-inclusion Criteria:&#xD;
&#xD;
          -  Chromosomal abnormality, severe congenital malformation&#xD;
&#xD;
          -  Toxic substance consumption during pregnancy&#xD;
&#xD;
          -  Sedative medication in progress, High frequencies ventilation in progress&#xD;
&#xD;
          -  Neurological damage: intraventricular haemorrhage stage 3 and 4, bilateral and expanse&#xD;
             periventricular leukomalacia lesions&#xD;
&#xD;
          -  Severe infectious state requiring haemodynamic support (inotropic drugs or&#xD;
             hemissucinate)&#xD;
&#xD;
          -  Participation to a other intervention research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliana PATKAI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Médecine et Réanimation néonatales de Port-Royal APHP.Centre - Université de Paris. Site Cochin.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliana PATKAI, MD</last_name>
    <phone>033 1 58413645</phone>
    <email>juliana.patkai@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>NICU of Port-Royal, Maternity of Port-Royal, Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Juliana PATKAI, MD</last_name>
      <phone>0033 1 58413645</phone>
      <email>juliana.patkai@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Alexandre C, De Jonckheere J, Rakza T, Mur S, Carette D, Logier R, Jeanne M, Storme L. [Impact of cocooning and maternal voice on the autonomic nervous system activity in the premature newborn infant]. Arch Pediatr. 2013 Sep;20(9):963-8. doi: 10.1016/j.arcped.2013.06.006. Epub 2013 Jul 23. French.</citation>
    <PMID>23890732</PMID>
  </reference>
  <reference>
    <citation>Filippa M, Devouche E, Arioni C, Imberty M, Gratier M. Live maternal speech and singing have beneficial effects on hospitalized preterm infants. Acta Paediatr. 2013 Oct;102(10):1017-20. doi: 10.1111/apa.12356. Epub 2013 Aug 8.</citation>
    <PMID>23848529</PMID>
  </reference>
  <reference>
    <citation>Williamson S, McGrath JM. What Are the Effects of the Maternal Voice on Preterm Infants in the NICU? Adv Neonatal Care. 2019 Aug;19(4):294-310. doi: 10.1097/ANC.0000000000000578.</citation>
    <PMID>31335378</PMID>
  </reference>
  <reference>
    <citation>Provenzi L, Broso S, Montirosso R. Do mothers sound good? A systematic review of the effects of maternal voice exposure on preterm infants' development. Neurosci Biobehav Rev. 2018 May;88:42-50. doi: 10.1016/j.neubiorev.2018.03.009. Epub 2018 Mar 10.</citation>
    <PMID>29535067</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 24, 2021</study_first_submitted>
  <study_first_submitted_qc>February 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2021</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preterm newborn</keyword>
  <keyword>Maternal voice reccording</keyword>
  <keyword>NIPE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

